These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24905064)

  • 21. [Hereditary Cushing's syndrome caused by primary bilateral macronodular adrenal hyperplasia due to ARMC5 mutation with concomitant primary hyperparathyroidism: the first known case in Russia].
    Mamedova EO; Vasilyev EV; Petrov VM; Izmailova NS; Buryakina SA; Rozhinskaya LY; Tiulpakov AN; Belaya ZE
    Probl Endokrinol (Mosk); 2019 Jun; 65(2):89-94. PubMed ID: 31271710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Macronodular adrenal hyperplasia causing Cushing's syndrome due to ARMC5 gene mutation.].
    Hella Z; Tőke J; Patócs A; Varga Z; Dabasi G; Kovács GL; Tóth M
    Orv Hetil; 2023 Aug; 164(32):1271-1277. PubMed ID: 37573559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel pathogenic variant of ARMC5 in a patient with primary bilateral macronodular adrenal hyperplasia: a case report.
    Wang W; Wei F
    BMC Endocr Disord; 2022 Aug; 22(1):211. PubMed ID: 35996143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary macronodular adrenal hyperplasia (PMAH) can be generated by a new ARMC5 germline variant (c.52C>T (p.Gln18X)).
    Zhang F; Lin X; Yu X
    Endocr J; 2020 Dec; 67(12):1179-1186. PubMed ID: 32713866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations.
    Tang P; Zhang J; Peng S; Yan X; Wang Y; Wang S; Zhang Y; Liu G; Xu J; Huang Y; Zhang D; Liu Q; Jiang J; Lan W
    BMC Endocr Disord; 2023 Apr; 23(1):77. PubMed ID: 37029354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel nonsense mutation in ARMC5 causes primary bilateral macronodular adrenocortical hyperplasia.
    He WT; Wang X; Song W; Song XD; Lu YJ; Lv YK; He T; Yu XF; Hu SH
    BMC Med Genomics; 2021 May; 14(1):126. PubMed ID: 33971873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New pathogenic variants in ARMC5 gene in a series of Italian patients affected by primary bilateral macronodular adrenocortical hyperplasia (PBMAH).
    Giacché M; Panarotto A; Mori L; Poliani PL; Lanzi R; Lena MS; Castellano M
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2126. PubMed ID: 36727580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of adrenal P450 aromatase (CYP19A1) in association with ARMC5-primary bilateral macronodular adrenocortical hyperplasia.
    Berthon A; Hannah-Shmouni F; Maria AG; Faucz FR; Stratakis CA
    J Steroid Biochem Mol Biol; 2019 Jul; 191():105316. PubMed ID: 31014964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors.
    Okuno Y; Fukuhara A; Otsuki M; Shimomura I
    JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35862218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report.
    Jojima T; Kogai T; Iijima T; Kato K; Sagara M; Kezuka A; Kase M; Sakurai S; Akimoto K; Sakumoto J; Namatame T; Ueki K; Hishinuma A; Kamai T; Usui I; Aso Y
    Eur J Endocrinol; 2020 Dec; 183(6):K7-K12. PubMed ID: 33105102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial ACTH-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia clinically affecting only female family members.
    Nies C; Bartsch DK; Ehlenz K; Wild A; Langer P; Fleischhacker S; Rothmund M
    Exp Clin Endocrinol Diabetes; 2002 Sep; 110(6):277-83. PubMed ID: 12373631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary Aldosteronism and ARMC5 Variants.
    Zilbermint M; Xekouki P; Faucz FR; Berthon A; Gkourogianni A; Schernthaner-Reiter MH; Batsis M; Sinaii N; Quezado MM; Merino M; Hodes A; Abraham SB; Libé R; Assié G; Espiard S; Drougat L; Ragazzon B; Davis A; Gebreab SY; Neff R; Kebebew E; Bertherat J; Lodish MB; Stratakis CA
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E900-9. PubMed ID: 25822102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel
    Eghbali M; Cheraghi S; Samanian S; Rad I; Meghdadi J; Akbari H; Honardoost M
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistence of Myelolipoma and Primary Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing's Syndrome.
    Larose S; Bondaz L; Mermejo LM; Latour M; Prosmanne O; Bourdeau I; Lacroix A
    Front Endocrinol (Lausanne); 2019; 10():618. PubMed ID: 31572300
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence and clinical features of armadillo repeat-containing 5 mutations carriers in a single center cohort of patients with bilateral adrenal incidentalomas.
    Morelli V; Elli FM; Frigerio S; Vena W; Palmieri S; Lucca C; Maffini MA; Contarino A; Bagnaresi F; Mantovani G; Arosio M
    Eur J Endocrinol; 2023 Aug; 189(2):242-251. PubMed ID: 37625448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function.
    Berthon A; Faucz FR; Espiard S; Drougat L; Bertherat J; Stratakis CA
    Hum Mol Genet; 2017 Sep; 26(18):3495-3507. PubMed ID: 28911199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ARMC5-negative primary bilateral macronodular adrenal hyperplasia.
    Sol B; Carprieaux M; De Leu N
    BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37419498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds.
    Gagliardi L; Hotu C; Casey G; Braund WJ; Ling KH; Dodd T; Manavis J; Devitt PG; Cutfield R; Rudzki Z; Scott HS; Torpy DJ
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):883-91. PubMed ID: 19018784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.
    Maria AG; Tatsi C; Berthon A; Drougat L; Settas N; Hannah-Shmouni F; Bertherat J; Faucz FR; Stratakis CA
    Endocr Relat Cancer; 2020 Sep; 27(9):509-517. PubMed ID: 32638579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genetic and molecular update on adrenocortical causes of Cushing syndrome.
    Lodish M; Stratakis CA
    Nat Rev Endocrinol; 2016 May; 12(5):255-62. PubMed ID: 26965378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.